KATIE MCALEER: Open Payments
NPI 1669136578 · HUNTINGDON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$899 in 41 payments from 11 companies in 2025. Trend: 2023 $711 · 2024 $604 · 2025 $899
Food & beverage: $899
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 25 | $566 |
| ABBVIE INC. | 3 | $62 |
| Teva Pharmaceuticals USA, Inc. | 3 | $57 |
| Collegium Pharmaceutical, Inc. | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Janssen Pharmaceuticals, Inc | 1 | $35 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Almatica Pharma LLC | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: CAPLYTA, VRAYLAR, AUSTEDO XR, Jornay PM, SPRAVATO, Auvelity, LOREEV XR, ABILIFY MAINTENA.
Industry payments across PA — which companies pay providers there.
